These compounds may interact with:

Tyrosine-protein kinase Lck

Potentially involved in: cancer; carcinoma; lymphopenia; astigmatism; preretinal fibrosis; spondylolisthesis; primary immunodeficiency disease; acquired immunodeficiency syndrome; hypersensitivity reaction type ii disease; autoimmune diseases; diarrhea; immunologic deficiency syndromes; panniculitis; failure to gain weight; infantile onset; pediatric failure to thrive; recurrent respiratory infections; immunodeficiency 22; autosomal recessive predisposition; atopic dermatitis

Disease data sourced from Pharos.